ID   CV-1/EBNA-1
AC   CVCL_6385
SY   CV-1/EBNA; CV1/EBNA
DR   CLO; CLO_0002642
DR   ATCC; CRL-10478
DR   Wikidata; Q54814870
RX   Patent=US5426048;
RX   PubMed=1833184;
CC   Group: Non-human primate cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10478.
CC   Transfected with: UniProtKB; P03211; EBV EBNA1.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from sampling site: Kidney.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops
HI   CVCL_0229 ! CV-1
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 23-09-21; Version: 12
//
RX   Patent=US5426048;
RA   Gearing D.P.;
RT   "DNA encoding a fusion receptor for oncostatin M and leukemia
RT   inhibitory factor.";
RL   Patent number US5426048, 20-Jun-1995.
//
RX   PubMed=1833184; DOI=10.1002/j.1460-2075.1991.tb07831.x;
RA   McMahan C.J., Slack J.L., Mosley B., Cosman D., Lupton S.D.,
RA   Brunton L.L., Grubin C.E., Wignall J.M., Jenkins N.A., Brannan C.I.,
RA   Copeland N.G., Huebner K., Croce C.M., Cannizzaro L.A., Benjamin D.,
RA   Dower S.K., Spriggs M.K., Sims J.E.;
RT   "A novel IL-1 receptor, cloned from B cells by mammalian expression,
RT   is expressed in many cell types.";
RL   EMBO J. 10:2821-2832(1991).
//